Vitamin D and subsequent all-age and premature mortality: a systematic review

BMC Public Health

Daniel MacKay¹  David Walsh³  Gerry McCartney²  Lynne Rush⁴ 

[1] Institute of Health and Wellbeing, University of Glasgow, Glasgow G12 8QQ, Scotland;NHS Health Scotland, Glasgow G2 2AF, Scotland;Glasgow Centre for Population Health, Glasgow G2 4DL, Scotland;NHS Greater Glasgow and Clyde, G12 0XH, Scotland

关键词: Meta-analysis;    Systematic review;    Premature mortality;    25OHD;    Vitamin D;   

Others  :  1162003
DOI  :  10.1186/1471-2458-13-679

 received in 2013-02-27, accepted in 2013-07-03,  发布年份 2013

【 摘 要 】

Background

All-cause mortality in the population < 65 years is 30% higher in Glasgow than in equally deprived Liverpool and Manchester. We investigated a hypothesis that low vitamin D in this population may be associated with premature mortality via a systematic review and meta-analysis.

Methods

Medline, EMBASE, Web of Science, the Cochrane Library and grey literature sources were searched until February 2012 for relevant studies. Summary statistics were combined in an age-stratified meta-analysis.

Results

Nine studies were included in the meta-analysis, representing 24,297 participants, 5,324 of whom died during follow-up. The pooled hazard ratio for low compared to high vitamin D demonstrated a significant inverse association (HR 1.19, 95% CI 1.12-1.27) between vitamin D levels and all-cause mortality after adjustment for available confounders. In an age-stratified meta-analysis, the hazard ratio for older participants was 1.25 (95% CI 1.14-1.36) and for younger participants 1.12 (95% CI 1.01-1.24).

Conclusions

Low vitamin D status is inversely associated with all-cause mortality but the risk is higher amongst older individuals and the relationship is prone to residual confounding. Further studies investigating the association between vitamin D deficiency and all-cause mortality in younger adults with adjustment for all important confounders (or using randomised trials of supplementation) are required to clarify this relationship.

【 授权许可】

   
2013 Rush et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 1.

【 参考文献 】

• [1]Wang TJ, Pencina MJ, Booth SL, et al.: Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117(4):503-511.
• [2]Grandi NC, Breitling LP, Brenner H: Vitamin D and cardiovascular disease: Systematic review and meta-analysis of prospective studies. Prev Med 2010, 51(3–4):228-233.
• [3]Elamin MB, Abu Elnour NO, Elamin KB, et al.: Vitamin D and cardiovascular outcomes: A systematic review and meta-analysis. J Clin End & Metab 2011, 96(7):1931-1942.
• [4]Mitri J, Muraru MD, Pittas AG: Vitamin D and type 2 diabetes: A systematic review. Eur J Clin Nutr 2011, 65(9):1005-1015.
• [5]Gandini S, Boniol M, Haukka J, et al.: Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011, 128(6):1414-1424.
• [6]Helzlsouer KJ, VDPP Steering C: Overview of the cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 2010, 172(1):4-9.
• [7]Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, et al.: Circulating 25-hydroxyvitamin D and risk of pancreatic cancer. Am J Epidemiol 2010, 172(1):81-93.
• [8]Scragg R: Vitamin D, and public health: An overview of recent research on common diseases and mortality in adulthood. Public Health Nutr 2011, 14(9):1515-1532.
• [9]Autier P, Gandini S: Vitamin D supplementation and total mortality - a meta-analysis of randomized controlled trials. Arch Intern Med 2007, 167(16):1730-1737.
• [10]Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Gluud C: Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011., 7CD007470
• [11]Zittermann A, Iodice S, Pilz S, Grant WB, Bagnardi V, Gandini S: Vitamin D deficiency and mortality risk in the general population: A meta-analysis of prospective cohort studies. Am J Clin Nutr 2012, 95(1):91-100.
• [12]Schöttker B, Ball D, Gellert C, Brenner H: Serum 25-hydroxyvitamin D levels and overall mortality. A systematic review and meta-analysis of prospective cohort studies. Ageing Res Rev 2013, 12(2):708-718.
• [13]Gillie O: An explanation and a plan. Health Research Forum. Report. 2008. http://www.healthresearchforum.org.uk/reports.html webcite (accessed 2nd August, 2012)
• [14]McCartney G, Collins C, Walsh D, Batty D: Accounting for Scotland’s excess mortality: Towards a synthesis. Glasgow Centre for Population Health. Report. 2011. http://www.gcph.co.uk/publications/238_accounting_for_scotlands_excess_mortality_towards_a_synthesis webcite (accessed 2nd August, 2012)
• [15]McLoone P, Boddy FA: Deprivation and mortality in Scotland, 1981 and 1991. BMJ 1994, 309(6967):1465-1470.
• [16]Leyland AH, Dundas R, McLoone P, Boddy FA: Cause-specific inequalities in mortality in Scotland: Two decades of change. A population-based study. BMC Public Health. 2007, 7:172. BioMed Central Full Text
• [17]Norman P, Boyle P, Exeter D, Feng Z, Popham F: Rising premature mortality in the UK’s persistently deprived areas: only a Scottish phenomenon? Soc Sci Med 2011, 73(11):1575-1584.
• [18]Hanlon P, Lawder RS, Buchanan D, et al.: Why is mortality higher in Scotland than in England and Wales? Decreasing influence of socioeconomic deprivation between 1981 and 2001 supports the existence of a ‘Scottish effect’. J Public Health 2005, 27(2):199-204.
• [19]Hyppönen E, Power C: Hypovitaminosis D in British adults at age 45 y: Nationwide cohort study of dietary and lifestyle predictors. Am J Clin Nutr 2007, 85(3):860-868.
• [20]Walsh D, Bendel N, Jones R, Hanlon P: It’s not ‘just deprivation’: Why do equally deprived UK cities experience different health outcomes? Public Health 2010, 124(9):487-495.
• [21]Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma G: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009, 339:b2535.
• [22]CASP tool for cohort studies. http://www.casp-uk.net/wp-content/uploads/2011/11/CASP-Cohort-Study-Checklist-31.05.13.pdf webcite (accessed 29th July 2013)
• [23]Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JAC: Metan: Fixed- and random-effects meta-analysis. Stata J 2008, 8(1):3-28.
• [24]Borenstein M, Hedges LV, Higgins JPT, Rothstein HR: Effect sizes based on binary data (2 x 2 tables). In Introduction to meta-analysis. Wiley; 2009:33-38.
• [25]Szulc P, Claustrat B, Delmas PD: Serum concentrations of 17beta-E2 and 25-hydroxycholecalciferol (25OHD) in relation to all-cause mortality in older men–the MINOS study. Clin Endocrinol (Oxf) 2009, 71(4):594-602.
• [26]Sterne JAC, Harbord RM: Funnel plots in meta-analysis. J Stata 2004, 4(2):127-141.
• [27]Harbord RM, Higgins JPT: Meta-regression in stata. J Stata 2008, 8(4):493-519.
• [28]Bates CJ, Hamer M, Mishra GD: A study of relationships between bone-related vitamins and minerals, related risk markers, and subsequent mortality in older British people: The national diet and nutrition survey of people aged 65 years and over. Osteoporosis Int 2012, 23(2):457-466.
• [29]Ford ES, Zhao G, Tsai J, Li C: Vitamin D and all-cause mortality among adults in USA: Findings from the national health and nutrition examination survey linked mortality study. Int J Epidemiol 2011, 40(4):998-1005.
• [30]Ginde AA, Scragg R, Schwartz RS, Jr Camargo CA: Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. J Am Geriatr Soc 2009, 57(9):1595-1603.
• [31]Hutchinson MS, Grimnes G, Joakimsen RM, Figenschau Y, Jorde R: Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: The Tromso study. Eur J Endocrinol 2010, 162(5):935-942.
• [32]Jia X, Aucott LS, McNeill G: Nutritional status and subsequent all-cause mortality in men and women aged 75 years or over living in the community. Br J Nutr 2007, 98(3):593-599.
• [33]Johansson H, Oden A, Kanis J, et al.: Low serum vitamin D is associated with increased mortality in elderly men: MrOS Sweden. Osteoporosis Int 2012, 23(3):991-999.
• [34]Melamed ML, Michos ED, Post W, Astor B: 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168(15):1629-1637.
• [35]Michaelsson K, Baron JA, Snellman G, et al.: Plasma vitamin D and mortality in older men: A community-based prospective cohort study. Am J Clin Nutr 2010, 92(4):841-848.
• [36]Semba RD, Houston DK, Bandinelli S, et al.: Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr 2010, 64(2):203-209.
• [37]Virtanen JK, Nurmi T, Voutilainen S, Mursu J, Tuomainen TP: Association of serum 25-hydroxyvitamin D with the risk of death in a general older population in Finland. Eur J Nutr 2011, 50(5):305-312.
• [38]Visser M, Deeg DJH, Puts MTE, Seidell JC, Lips P: Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 2006, 84(3):616-622.
• [39]Bates C, Mishra G: Updated hazard ratios for 25OHD and all-cause mortality, data from the national diet and nutrition survey of people aged 65 years and over. Personal communication; 2012.
• [40]Bergstrom A, Hsieh CC, Lindblad P, Lu CM, Cook NR, Wolk A: Obesity and renal cell cancer–a quantitative review. Br J Cancer 2001, 85:984-990.
• [41]Gagnier J, Moher D, Boon H, Bombardier C, Beyene J: An empirical study using permutation-based resampling in meta-regression. Syst Rev 2012, 1(1):18. BioMed Central Full Text
• [42]Hollis BW, Horst RL: The assessment of circulating 25(OH)D and 1,25(OH)2D: Where we are and where we are going. J Ster Biochem Mol Biol 2007, 103(3–5):473-476.